PATRICK LYONS: Open Payments
NPI 1003218041 · NORTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 39 payments from 15 companies in 2025. Trend: 2023 $641 · 2024 $938 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $205 |
| Novo Nordisk Inc | 6 | $144 |
| ABBVIE INC. | 4 | $115 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| PFIZER INC. | 2 | $51 |
| Abbott Laboratories | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Seqirus USA Inc | 2 | $36 |
Products named: JARDIANCE, QULIPTA, Ozempic, REXULTI, TRELEGY ELLIPTA, MOUNJARO, VOQUEZNA, FREESTYLE LIBRE 3.
Industry payments across MA — which companies pay providers there.
